Share Graph – Esperite

Search for:

Share Graph

Search for:

European Select Growth Opportunities Fund subscribes to the 19th tranche of its investment today and has agreed to provide up to EUR 7.25 million in additional funding
ESPERITE NV (ESP) LAUNCHS NEW AGAATA Dx, DIAGNOSTIC SYSTEM WITH MACHINE LEARNING CAPABILITIES FOR GENETIC CLINICAL LABORATORIES.
ESPERITE (ESP) expects publication of Annual Report 2017 before 18 june 2018
Esperite NV (ESP) with The Cell Factory has signed the agreement with the PHARM CRO to start preparation for the first-in-man clinical trials in treatment of Crohn’s disease.
ESPERITE (ESP) : L1 Capital subscribes to the 18th tranche of investment today

Esperite N.V. - Herengracht 282
1016 BX Amsterdam - The Netherlands

Tel. +31 (0) 575 548 998
Email: ir@esperite.com